Darapladib
| CAS No. | 356057-34-6 | Cat. No. | BCP04908 |
| Name | Darapladib | ||
| Synonyms | SB-480848; SB480848; SB 480848; | ||
| Formula | C36H38F4N4O2S | M. Wt | 666.77 |
| Description | Darapladib, is a novel inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme that may link lipid metabolism with inflammation, leading to the increased stability of atherosclerotic plaques present in the major arteries. Darapladib is being studied as a possible add-on treatment for atherosclerosis. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | Phospholipase | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.